| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/10/1994 | US5310740 Renin inhibitors |
| 05/10/1994 | US5310737 Benzo-fused lactams that promote the release of growth hormone |
| 05/10/1994 | US5310729 Interferon-related polypeptides as CR2 ligands and their use for modulating immune cell functions |
| 05/10/1994 | US5310728 Method for treating corneal endothelial wounds |
| 05/10/1994 | US5310727 And human albumin, storage stability |
| 05/10/1994 | US5310726 Antifungal, antiparasite, echinicandin B derivative |
| 05/10/1994 | US5310663 Affinity peptides |
| 05/10/1994 | US5310661 Nucleic acid encoding the α chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| 05/10/1994 | US5310654 Method for determining virulence of Yersinia |
| 05/10/1994 | US5310651 DNA probes of human immunodeficiency virus type 2 (HIV-2), and methods employing these probes for dectecting the presence of HIV-2 |
| 05/10/1994 | US5310551 Method for inhibiting pulmonary oxygen toxicity |
| 05/10/1994 | US5310550 Platelet deficiency |
| 05/10/1994 | US5310541 In situ generation of hydrogen peroxide, prevention of oral disease in livestock and other domestic animals |
| 05/10/1994 | CA1329446C Peptides with laminin activity |
| 05/10/1994 | CA1329444C Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 05/10/1994 | CA1329397C Hydroxamic acid based collagenase inhibitors |
| 05/06/1994 | CA2109392A1 Composition and method for reducing the risk of hypotension |
| 05/05/1994 | DE4335366A1 Verfahren zur Herstellung eines kristallinen Typ A Botulinum Toxins als therapeutische Arznei A process for preparing a crystalline botulinum toxin type A as a therapeutic drug |
| 05/05/1994 | DE4307352A1 Präparat zur Therapie und insbesondere Prophylaxe von Erkrankungen des Verdauungstraktes Drug for the treatment and prophylaxis of particular diseases of the digestive tract |
| 05/05/1994 | DE4237244A1 Verfahren zur Herstellung hochreiner humaner GAD-1- und GAD-2- Proteine Process for the preparation of highly pure human GAD-1 and GAD-2 proteins |
| 05/05/1994 | DE4237129A1 Application of complementary peptide(s) in oncology and cardiology - pref. using peptide(s) complementary to human papilloma virus type 16 onco-protein E7, binding to retino-blastoma proteins |
| 05/05/1994 | DE3348289C2 Pure human tissue plasminogen activator |
| 05/04/1994 | EP0595743A1 Bihaptinic derivatives for binding for technetium or rhenium, process for their preparation, application for diagnosis and therapy, kits and immunological reactants comprising them |
| 05/04/1994 | EP0595716A1 Enhancer for the antianemia effect of erythropoietin |
| 05/04/1994 | EP0595659A2 Extracellular matrix receptor ligands that modulate leukocyte function |
| 05/04/1994 | EP0595610A1 Benzo-fused lactams |
| 05/04/1994 | EP0595241A2 Determination and inhibition of malic enzyme in tumor cells |
| 05/04/1994 | EP0595133A2 Prodrugs, their preparation and use as medicaments |
| 05/04/1994 | EP0594999A1 Phospholipid derivatives containing higher elements of the fifth main group |
| 05/04/1994 | EP0594879A1 Cathepsin L-specific monoclonal antibodies, hybridomas for producing the same and a method of using the same |
| 05/04/1994 | EP0594847A1 Dna coding for human fk506-binding protein and expression thereof |
| 05/04/1994 | EP0594803A1 Method for reducing side-effects of a drug |
| 05/04/1994 | EP0594782A1 Syringe system |
| 05/04/1994 | EP0594764A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594710A1 Tyrosine kinase |
| 05/04/1994 | EP0594677A1 Antiviral liponucleosides: treatment of hepatitis b |
| 05/04/1994 | EP0594669A1 NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO) |
| 05/04/1994 | EP0594656A1 4-amino-3-hydroxycarboxylic acid derivatives |
| 05/04/1994 | EP0594610A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
| 05/04/1994 | EP0594592A1 A growth factor in connection with artificial transplants. |
| 05/04/1994 | EP0594586A1 Hiv protease inhibitors |
| 05/04/1994 | EP0428700B1 Irreversible bombesin antagonists |
| 05/04/1994 | EP0410006B1 Eye drops for healing wound of corneal epithelium |
| 05/04/1994 | EP0148843B2 A concentrate of the antihemophilic factor viii and a process for producing it |
| 05/04/1994 | CN1086262A New DNA sequences |
| 05/04/1994 | CN1086221A Peptide compounds |
| 05/04/1994 | CN1086142A Vaccines |
| 05/04/1994 | CN1086102A A nutritive composition and a process for its production |
| 05/03/1994 | US5308889 Medical article for surgery |
| 05/03/1994 | US5308847 Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
| 05/03/1994 | US5308841 Amino and nitro containing tricyclic compounds useful as inhibitors of ACE |
| 05/03/1994 | US5308836 Pharmaceutical composition of stabilized [Leu13 ]-motilin-Hse |
| 05/03/1994 | US5308834 Treatment of endotoxin-associated shock and prevention thereof using a BPI protein |
| 05/03/1994 | US5308833 Method for treating hepatitis B carriers with minimal disease |
| 05/03/1994 | US5308832 Nutritional product for persons having a neurological injury |
| 05/03/1994 | US5308752 Determination of antibody binding to dystrophin-protein complex |
| 05/03/1994 | US5308701 Encapsulation biological material |
| 05/03/1994 | US5308626 Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (ADCC) treatment of cancer and other diseases |
| 05/03/1994 | US5308617 Protein heparin conjugates |
| 05/03/1994 | CA2108808A1 Man-made saliva fluids |
| 05/03/1994 | CA1329307C Purification of monomeric interferon |
| 05/03/1994 | CA1329157C Method for activating gene technologically produced, heterologous, eucaryotic proteins comprising disulphide bridges after expression in procaryotes |
| 05/03/1994 | CA1329122C Prevention of bovine respiratory disease complex in cattle by administration of interferon |
| 05/03/1994 | CA1329121C Stabilisation of therapeutically active proteins in pharmaceutical preparations |
| 05/03/1994 | CA1329119C Cytotoxic therapy |
| 05/01/1994 | CA2109398A1 Extracellular matrix receptor ligands that modulate leukocyte function |
| 04/29/1994 | CA2107443A1 Benzo-fused lactams |
| 04/28/1994 | WO1994009369A1 Method for screening hiv-1 positive individuals using antibodies against sulfatide |
| 04/28/1994 | WO1994009364A1 Method of inhibiting binding of amyloid precursor protein to beta-amyloid protein |
| 04/28/1994 | WO1994009160A1 Method of inhibiting replication of hyperproliferative cells |
| 04/28/1994 | WO1994009150A1 Monoclonal antibodies to prostate cells |
| 04/28/1994 | WO1994009149A1 Monoclonal antibody |
| 04/28/1994 | WO1994009138A1 Interleukin-6 receptor antagonists |
| 04/28/1994 | WO1994009137A1 Antibodies against type 2 tumor necrosis factor receptor |
| 04/28/1994 | WO1994009136A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/28/1994 | WO1994009134A2 Modified ciliary neurotrophic factors |
| 04/28/1994 | WO1994009131A1 Recombinant specific binding protein |
| 04/28/1994 | WO1994009130A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof |
| 04/28/1994 | WO1994009128A1 Therapeutic treatment for inhibiting vascular restenosis |
| 04/28/1994 | WO1994009126A2 Acyl coenzyme a: cholesterol acyltransferase (acat) |
| 04/28/1994 | WO1994009120A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 04/28/1994 | WO1994009119A1 Remyelination using neural stem cells |
| 04/28/1994 | WO1994009039A1 New protein that lengthens blood coagulation time, derived from the land leech haemadipsa sylvestris |
| 04/28/1994 | WO1994009038A1 Process for producing native intravenously administrable stabilised immunoglobin |
| 04/28/1994 | WO1994009037A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS |
| 04/28/1994 | WO1994009034A1 Clot directed anticoagulant, process for making same and methods of use |
| 04/28/1994 | WO1994009031A1 Analogues of cholecystokinin (30-33) containing an alpha-substituted aminoacid |
| 04/28/1994 | WO1994009030A1 Peptide compound and process for producing the same |
| 04/28/1994 | WO1994009029A1 Fibrinogen receptor antagonists |
| 04/28/1994 | WO1994009027A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 04/28/1994 | WO1994009023A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION |
| 04/28/1994 | WO1994009010A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 04/28/1994 | WO1994008941A1 Arginine keto-amide enzyme inhibitors |
| 04/28/1994 | WO1994008623A1 Injectable lecithin gel |
| 04/28/1994 | WO1994008622A1 Pharmaceutical compositions containing a calcitonin |
| 04/28/1994 | WO1994008621A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies |
| 04/28/1994 | WO1994008620A1 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen |
| 04/28/1994 | WO1994008619A1 Treatment of autoimmune and inflammatory disorders |
| 04/28/1994 | WO1994008618A1 Oral tolerance and immune suppression in the treatment of aids |